| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 503,980 | 498,983 | 469,309 | 437,111 | | Cost of Revenue |
-
|
-
|
-
| (1,070,572) | | | Gross Profit |
-
| 498,983 | 469,309 | 1,507,683 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 276,771 | 467,023 | 462,784 | 1,501,799 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
| 3,352 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 12,542 | 28,608 | 6,525 | 5,884 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 22,501 | 28,608 | 6,525 | 5,884 | | Interest Expense | 3,338 | 3,357 | 3,264 | 3,333 | | Income Before Tax | 19,163 | 25,251 | 3,261 | 2,551 | | Income Tax Expense | 1,079 | 6,591 | (671) | 571 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 18,084 | 18,660 | 3,932 | 1,980 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 18,084 | 18,660 | 3,932 | 1,980 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $18,084 | $18,660 | $3,932 | $1,980 |
|
0.02% Nasdaq 
0.33%
Income Statement
